Back

Investigation of the effects of a novel hERG-activating peptide on APD and IKr function in LQT2 syndrome rabbit cardiomyocytes

8 July 2026 (10:30 - 12:30)
Organised by: Logo
Seminar Presentation Part of: POSTER SESSION 2 Basic Science Delegate Premium access 50th EWGCCE Meeting 2026 WG on Cardiac Cellular Electrophysiology

42 More presentations in this session

Presentation thumbnail
A ZFPM2 regulatory region associated to Brugada syndrome plays an essential role in cardiac electrical activity and development
Abstract
Presentation thumbnail
Mechanobiological distinction of focal and conductive arrhythmias by AFM
Abstract
Presentation thumbnail
Promising QT-shortening effect of the endocannabinoid N-arachidonoyl-L-Serine (ARA-S) in a transgenic rabbit model of long QT syndrome type 1
Abstract
Presentation thumbnail
Human living cardiac slices as a platform for antiarrhythmic drug testing
Abstract
Presentation thumbnail
Electrophysiological characterization of human cardioids at different maturation stages
Abstract

Access the full session

Session thumbnail
POSTER SESSION 2

The Event

Event poster

50th EWGCCE Meeting 2026

8 July 2026 10:30 CET
You may be interested in
thumbnail
Congress Presentation
In vivo KCNQ1-suppression-replacement gene therapy in transgenic rabbits with type 1 long QT syndrome
17 April 2023
thumbnail
Congress Session
Clinical Case Award: clinical - ventricular arrhythmias
30 March 2025
thumbnail
Congress Presentation
Metabolic treatment of an electrical disease? - Beneficial APD/QT prolongation by L-Carnitine in transgenic SQT1 rabbit models
29 August 2021
thumbnail
Congress Presentation
Unravelling the signaling pathway downstream of the neurokinin receptor in atrium: discovering novel anti-arrhythmic targets for treatment of atrial fibrillation
28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources